Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of RF16001 for post-hemorrhoidectomy analgesia
CTR20252700Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Mar 2026; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20252700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252700.